scholarly journals 1266P Initial results from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3 protein) and pembrolizumab in patients with PD-L1 unselected first-line metastatic non-small cell lung carcinoma

2020 ◽  
Vol 31 ◽  
pp. S818
Author(s):  
M. Majem ◽  
E. Felip ◽  
B. Doger ◽  
M. Akay ◽  
E. Carcereny ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
Cell Lung Carcinoma ◽  
Initial Results

Phase II Study of Ifosfamide Combined with Mesna Uroprotection in Advanced Non-Small-Cell Lung Carcinoma and Other Solid Tumors

1984 ◽  
Vol 70 (5) ◽  
pp. 433-437 ◽  
Author(s):  
Maria Teresa Nobile ◽  
Riccardo Rosso ◽  
Fulvio Brema ◽  
Angela Cinquegrana ◽  
Leonardo Santi
Keyword(s):  
Solid Tumors ◽  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma

Phase II study of fotermustine in the treatment of inoperable non small cell lung carcinoma (NSCLC): Finalreport

1993 ◽  
Vol 29 ◽  
pp. S161
Author(s):  
T. Le Chevalier ◽  
A. Monnier ◽  
J.Y. Douillard ◽  
J.L. Pujol ◽  
A. Riviere ◽  
...  
Keyword(s):  
Phase Ii ◽  
Lung Carcinoma ◽  
Phase Ii Study ◽  
Small Cell Lung Carcinoma ◽  
Small Cell ◽  
Small Cell Lung ◽  
Cell Lung Carcinoma
Sign in / Sign up

Export Citation Format

Share Document